
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. — Investor Relations & Filings
Shenzhen Hepalink Pharmaceutical Group Co., Ltd., established in 1998, is a leading multinational biopharmaceutical company focused on delivering high-quality, safe, and effective medicines globally. The company operates three primary business segments. It is recognized as a global leader in the heparin industry chain, maintaining a comprehensive closed-loop layout that encompasses Active Pharmaceutical Ingredients (APIs) and finished dose products, such as heparin and enoxaparin sodium injections, prolongin, inhixa, and neoparin. Additionally, Hepalink provides specialized CDMO (Contract Development and Manufacturing Organization) services, focusing on recombinant biologics (biomacromolecules) and gene therapy products. The third segment involves the investment, development, and commercialization of differentiated innovative drugs, driven by unmet clinical needs. Hepalink's operations span over 50 countries and regions.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | 2026-05-26 | English | |
| FINAL DIVIDEND FOR THE YEAR ENDED 31 DECEMBER 2025 (UPDATED) | 2026-05-22 | English | |
| An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | 2026-05-22 | English | |
| An announcement has just been published by the issuer in the Chinese section of this website, a corresponding version of which may or may not be published in this section | 2026-05-22 | English | |
| LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS | 2026-05-22 | English | |
| POLL RESULTS OF THE 2025 ANNUAL GENERAL MEETING HELD ON MAY 22, 2026 | 2026-05-22 | English |
Browse filings by year
7 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Shenzhen Hepalink Pharmaceutical Group Co., Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/51201/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=51201 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=51201 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=51201 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 51201}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (id: 51201)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.